DJI46,429.49+0.66%
GDAXI22,619.65-1.47%
GSPC6,591.90+0.54%
HSI24,856.43-1.89%
IXIC21,929.83+0.77%
N22553,603.65-0.27%
AAPL252.62+0.39%
AMZN211.71+2.16%
CL93.53+3.55%
EURUSD1.1565+0.00%
GBPUSD1.3357-0.08%
GC4,421.40-2.88%
GOOG289.59+0.13%
JPM295.42+1.03%
META594.89+0.33%
MSFT371.04-0.46%
NVDA178.68+1.99%
TSLA385.95+0.76%
DJI46,429.49+0.66%
GDAXI22,619.65-1.47%
GSPC6,591.90+0.54%
HSI24,856.43-1.89%
IXIC21,929.83+0.77%
N22553,603.65-0.27%
AAPL252.62+0.39%
AMZN211.71+2.16%
CL93.53+3.55%
EURUSD1.1565+0.00%
GBPUSD1.3357-0.08%
GC4,421.40-2.88%
GOOG289.59+0.13%
JPM295.42+1.03%
META594.89+0.33%
MSFT371.04-0.46%
NVDA178.68+1.99%
TSLA385.95+0.76%
DJI46,429.49+0.66%
GDAXI22,619.65-1.47%
GSPC6,591.90+0.54%
HSI24,856.43-1.89%
IXIC21,929.83+0.77%
N22553,603.65-0.27%
AAPL252.62+0.39%
AMZN211.71+2.16%
CL93.53+3.55%
EURUSD1.1565+0.00%
GBPUSD1.3357-0.08%
GC4,421.40-2.88%
GOOG289.59+0.13%
JPM295.42+1.03%
META594.89+0.33%
MSFT371.04-0.46%
NVDA178.68+1.99%
TSLA385.95+0.76%
LIVE
USA Seeking Alpha EN

Dyadic International GAAP EPS of -$0.23 in-line, revenue of $3.09M misses by $0.77M

Mar 26, 2026 &03192626202631; 08:19 UTC seekingalpha.com Trending 2/5
Read original on seekingalpha.com ↗
Negative for markets
Sentiment score: -72/100
Moderate impact Short-term (days)
WHAT THIS MEANS
Dyadic International reported Q3 GAAP EPS of -$0.23 (in-line) but revenue of $3.09M missed consensus by $0.77M (~20% shortfall), signaling weak commercial traction. Fresh miss on top-line with elevated VIX suggests risk-off sentiment may amplify negative reaction.
AI CONFIDENCE
68% High
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
DYAX
DYAXStock
Expected to decline
Material revenue miss of $0.77M (~20% below consensus) on small revenue base indicates execution shortfall; EPS in-line masks underlying weakness. Fresh catalyst (6 min old) not yet fully absorbed by market.
S&P 500
^GSPCIndex
High volatility expected
S&P 500 up +0.54% but VIX spiked +4.46% to 26.46—divergence signals underlying fragility; biotech/small-cap weakness may pressure broader sentiment.
PRICE HISTORY
Loading chart...
SUGGESTED ACTION
DYAX likely to gap down on open; small biotech with revenue misses typically see 5-12% single-day declines in elevated VIX. Consider short entry only if pre-market shows <-5% move (avoid chasing). Risk/reward unfavorable if already down >6%. [MOVE:-8.5%]
KEY SIGNALS
Revenue miss 20% below consensus—execution riskNegative EPS continues—path to profitability unclearVIX spike +4.46% suggests risk-off environment amplifying small-cap selloffFresh catalyst (6 min)—limited market reaction time
SECTORS INVOLVED
BiotechnologyHealthcare
Analysis generated on Mar 26, 2026 at 08:25 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.